Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Control-IQ Technology 2.0 Adult and Adolescent Feasibility Study

NCT: NCT05014789 · COMPLETED

NCT IDNCT05014789
StatusCOMPLETED
Start Date2021-08-19
Completion2021-12-20
SponsorTandem Diabetes Care, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of this study is to obtain preliminary safety and performance data on planned improvements to Control-IQ technology.

Frequently Asked Questions

What is Control-IQ Technology 2.0 Adult and Adolescent Feasibility Study?

Control-IQ Technology 2.0 Adult and Adolescent Feasibility Study is a clinical trial registered under NCT05014789. Current status: COMPLETED.

What is the status of NCT05014789?

The current status of NCT05014789 (Control-IQ Technology 2.0 Adult and Adolescent Feasibility Study) is: COMPLETED.

When did Control-IQ Technology 2.0 Adult and Adolescent Feasibility Study start?

Control-IQ Technology 2.0 Adult and Adolescent Feasibility Study started on 2021-08-19.

Related Devices

K200467Control-IQ TechnologyTandem Diabetes Care, Inc. K232382Control-IQ TechnologyTandem Diabetes Care, Inc. K243823Control-IQ+ technologyTandem Diabetes Care, Inc. K250798Control-IQ+ technologyTandem Diabetes Care, Inc. K260429Control-IQ+ technologyTandem Diabetes Care, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑